Journal profile · RESPIRATORY SYSTEM
International Journal of Chronic Obstructive Pulmonary Disease
ISSN 1176-9106 · eISSN 1178-2005 · Dove Medical Press Ltd. · NEW ZEALAND
International Journal of Chronic Obstructive Pulmonary Disease: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.1; JCR Q1 (journal website); fully open access; APC about USD 4,320; median 95 days to acceptance (111 articles, last 24 months); acceptance rate 18% (journal website); 323 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
International Journal of Chronic Obstructive Pulmonary Disease is published by Dove Medical Press Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases and Respiratory Support and Mechanisms, together about 57.1% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Editor-in-Chief: Professor Richard E Russell The International Journal of Chronic Obstructive Pulmonary Disease is an international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals. All meta-analyses require a pre-submission check prior to submitting to the International Journal of Chronic Obstructive Pulmonary Disease. Please complete the pre-submission check form here. Updated 16 July 2025
From the journal's Aims & Scope
Research area (LetPub): RESPIRATORY SYSTEM
Editor-in-chief Richard E RussellPublisher website
Editorial board by country: 2 in mainland China (about 4%); most named United States 14, Italy 9, United Kingdom 8, Greece 7, Mainland China 2 (49 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine39.8%
- Asthma and respiratory diseasesMedicine8.9%
- Respiratory Support and MechanismsMedicine8.3%
- Respiratory and Cough-Related ResearchMedicine7.1%
- Delphi Technique in ResearchSocial Sciences6%
- Inhalation and Respiratory Drug DeliveryMedicine4.6%
- Chronic Disease Management StrategiesMedicine3.2%
- Pediatric health and respiratory diseasesHealth Professions2.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Respiratory System | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Respiratory System | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Respiratory System | Zone 3 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q1 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.1LetPub ·
- Impact factor (publisher) 2025
- 3.9Publisher website ·
- 5-year impact factor (publisher)
- 5.6Publisher website ·
- CiteScore 2026-06
- 5.6LetPub ·
- CiteScore (publisher) 2025
- 1.27Publisher website ·
- SJR 2026-06
- 1.15LetPub ·
- SNIP 2026-06
- 1.27LetPub ·
- h-index
- 54LetPub ·
- h-index
- 113OpenAlex ·
- i10-index
- 2,641OpenAlex ·
- 2-year mean citedness
- 3.42OpenAlex ·
- Self-citation rate
- 12.2%LetPub ·
- Share of gold OA articles
- 99.61%LetPub ·
Volume
- Articles per year
- 316LetPub ·
- Downloads per year (publisher)
- 390,867Publisher website ·
Articles by year OpenAlex count · 4,273 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 298 | 298 | 52 |
| 2025 | 323 | 323 | 1,058 |
| 2024 | 220 | 220 | 1,767 |
| 2023 | 252 | 252 | 3,131 |
| 2022 | 253 | 253 | 3,910 |
| 2021 | 314 | 314 | 5,763 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
95 daysMedian, submission to acceptance · P25–P75 70 days – 124 days
- Acceptance to online
- median 16 days (111 articles)
- Submission to online
- median 116 days
- Sample
- 111 articles with submission and acceptance dates (667 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Acceptance rate (publisher)
- 18%Publisher website ·
- Desk decision
- 45 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 4,320 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,836 | — | — | |
| LetPub | USD 3,300 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- case reportAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
- reviewAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
Policy excerpts from the journal's websitePublication ethics, Plagiarism
- Publication ethics
Member of COPE Model summary
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Source ↗Publisher website ·- Plagiarism
All submitted manuscripts are checked for plagiarism using Crossref Similarity Check (powered by iThenticate). Model summary
Please be aware that Dove Medical Press checks ALL submitted manuscripts for plagiarism. We use Crossref Similarity Check (powered by iThenticate).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Dove Medical Press Ltd.
- Country or region
- NEW ZEALAND
- Language
- English
- ISSN
- 1176-9106
- Electronic ISSN
- 1178-2005
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about International Journal of Chronic Obstructive Pulmonary Disease
What CAS zone is International Journal of Chronic Obstructive Pulmonary Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, International Journal of Chronic Obstructive Pulmonary Disease is in Zone 3 of Medicine, and in Zone 3 of the minor category Respiratory System. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of International Journal of Chronic Obstructive Pulmonary Disease?
The latest impact factor listed by LetPub is 4.1; CiteScore 5.6, h-index 113.
How long does peer review take at International Journal of Chronic Obstructive Pulmonary Disease?
Based on the dates recorded on 111 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 95 days (interquartile range 70–124 days); authors report an average review time of about 16 weeks; the journal's website gives an acceptance rate of 18%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is International Journal of Chronic Obstructive Pulmonary Disease in?
The journal's website gives JCR Q1 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Where are the editorial board members of International Journal of Chronic Obstructive Pulmonary Disease based?
Of the 49 board members whose country the journal's board page names, 2 (about 4%) are in mainland China; the countries named most often are United States (14), Italy (9) and United Kingdom (8). Counted from the institutions listed on the board page; for reference only.
Which databases index International Journal of Chronic Obstructive Pulmonary Disease?
According to LetPub and DOAJ records, International Journal of Chronic Obstructive Pulmonary Disease is indexed in SCIE, Scopus and DOAJ.
Is International Journal of Chronic Obstructive Pulmonary Disease open access, and what is the APC?
International Journal of Chronic Obstructive Pulmonary Disease is a fully open-access journal. APC about USD 4,320.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .